In the current study, we investigated the functional significance of nicotine and α7nAChR in HCC progression and therapy resistance, the molecular mechanisms underlying its oncogenic role in HCC, and the potential of DHCT treatment to reverse the effects of nicotine in HCC. Here, CHRNA7 is linked to hepatocellular carcinoma.